X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8327) 8327
Book Review (1040) 1040
Publication (413) 413
Newsletter (157) 157
Book Chapter (34) 34
Conference Proceeding (34) 34
Dissertation (17) 17
Newspaper Article (14) 14
Magazine Article (8) 8
Web Resource (4) 4
Book / eBook (2) 2
Government Document (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6548) 6548
humans (5877) 5877
mitoxantrone (4409) 4409
male (3618) 3618
oncology (3061) 3061
middle aged (2680) 2680
female (2647) 2647
aged (2214) 2214
antineoplastic combined chemotherapy protocols - therapeutic use (1991) 1991
mitoxantrone - administration & dosage (1946) 1946
chemotherapy (1942) 1942
adult (1926) 1926
cancer (1418) 1418
prostate cancer (1369) 1369
docetaxel (1334) 1334
treatment outcome (1291) 1291
animals (1100) 1100
prostatic neoplasms - drug therapy (983) 983
prednisone (956) 956
hematology (951) 951
mitoxantrone - therapeutic use (928) 928
antineoplastic agents - therapeutic use (908) 908
therapy (871) 871
antineoplastic combined chemotherapy protocols - adverse effects (842) 842
pharmacology & pharmacy (818) 818
aged, 80 and over (803) 803
mitoxantrone plus prednisone (799) 799
mitoxantrone - adverse effects (766) 766
mitoxantrone - pharmacology (722) 722
urology & nephrology (699) 699
cytarabine - administration & dosage (692) 692
care and treatment (634) 634
antineoplastic agents - pharmacology (620) 620
survival (608) 608
prostatic neoplasms - pathology (603) 603
remission induction (596) 596
breast neoplasms - drug therapy (571) 571
research (568) 568
survival analysis (542) 542
doxorubicin (539) 539
mice (536) 536
disease-free survival (535) 535
prognosis (535) 535
multiple sclerosis (527) 527
drug administration schedule (524) 524
adolescent (522) 522
trial (522) 522
drug resistance, neoplasm (517) 517
mitoxantrone hydrochloride (516) 516
cell line, tumor (513) 513
antineoplastic combined chemotherapy protocols - administration & dosage (505) 505
dose-response relationship, drug (496) 496
antineoplastic agents - administration & dosage (479) 479
survival rate (470) 470
cyclophosphamide - administration & dosage (469) 469
metastasis (464) 464
etoposide - administration & dosage (462) 462
drug therapy (459) 459
abridged index medicus (437) 437
combined modality therapy (437) 437
retrospective studies (432) 432
carcinoma (426) 426
leukemia, myeloid, acute - drug therapy (408) 408
analysis (401) 401
medicine & public health (389) 389
time factors (384) 384
taxoids - administration & dosage (381) 381
cyclophosphamide (380) 380
antineoplastic agents - adverse effects (377) 377
prostate-specific antigen - blood (368) 368
neoplasm metastasis (366) 366
expression (365) 365
taxoids - therapeutic use (363) 363
clinical neurology (357) 357
disease progression (351) 351
apoptosis (348) 348
cells (343) 343
breast cancer (341) 341
drug resistance (340) 340
follow-up studies (338) 338
prednisone - administration & dosage (335) 335
health aspects (334) 334
phase-ii (331) 331
recurrence (331) 331
prostatic neoplasms, castration-resistant - drug therapy (327) 327
double-blind (323) 323
phase-ii trial (319) 319
multiple sclerosis - drug therapy (315) 315
antineoplastic agents (310) 310
men (309) 309
biochemistry & molecular biology (308) 308
clinical trials as topic (307) 307
doxorubicin - administration & dosage (295) 295
atp binding cassette transporter, sub-family g, member 2 (294) 294
vincristine - administration & dosage (293) 293
neoplasm staging (290) 290
increased survival (286) 286
tumor cells, cultured (285) 285
combination (283) 283
drugs (283) 283
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7836) 7836
German (212) 212
French (151) 151
Japanese (126) 126
Chinese (84) 84
Spanish (60) 60
Russian (39) 39
Italian (12) 12
Polish (12) 12
Czech (11) 11
Hungarian (5) 5
Korean (4) 4
Portuguese (4) 4
Turkish (3) 3
Bulgarian (2) 2
Norwegian (2) 2
Swedish (2) 2
Ukrainian (2) 2
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
12/2009
Background and Purpose : Mitoxantrone is an approved disease modifying agent for treatment of multiple sclerosis (MS). The aim of the study was to assess its... 
multiple sclerosis | novantrone | Mitoxantrone
Web Resource
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9747, pp. 1147 - 1154
Summary Background Cabazitaxel is a novel tubulin-binding taxane drug with antitumour activity in docetaxel-resistant cancers. We aimed to compare the efficacy... 
Internal Medicine | EVERY 3 WEEKS | MEDICINE, GENERAL & INTERNAL | PAIN | SOLID TUMORS | END-POINTS | TAXANE | CHEMOTHERAPY | ESTRAMUSTINE | Prostatic Neoplasms - metabolism | Mitoxantrone - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Drug Resistance, Neoplasm | Male | Prostatic Neoplasms - immunology | Antineoplastic Agents, Hormonal - therapeutic use | Treatment Failure | Neutropenia - chemically induced | Mitoxantrone - adverse effects | Prostatic Neoplasms - drug therapy | Taxoids - adverse effects | Prostatic Neoplasms - pathology | Prednisone - administration & dosage | Prednisone - adverse effects | Drug Administration Schedule | Administration, Oral | Kaplan-Meier Estimate | Treatment Outcome | Disease Progression | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Biomarkers, Tumor - blood | Disease-Free Survival | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Androgen Antagonists - therapeutic use | Aged | Infusions, Intravenous | Pain Measurement | Dosage and administration | Prednisone | Research | Drug therapy | Prostate cancer | Mitoxantrone hydrochloride | Studies | Chemotherapy | Medical imaging | Physicians | Family medical history | Radiation therapy | Clinical medicine | Cancer therapies | Index Medicus | Abridged Index Medicus
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2011, Volume 48, Issue 1, pp. 85 - 93
Journal Article
Journal Article
Journal Article
Biomaterials, ISSN 0142-9612, 2012, Volume 33, Issue 28, pp. 6739 - 6747
Journal Article
Journal of Neurology, ISSN 0340-5354, 10/2008, Volume 255, Issue 10, pp. 1449 - 1463
This review updates and extends earlier Consensus Reports related to current basic and escalating immunomodulatory treatments in multiple sclerosis (MS). The... 
Multiple Sclerosis | Neurology | randomized trials | Neurosciences | Medicine & Public Health | glatirameracetate | treatment escalation | interferon β | immunotherapy | Neuroradiology | monoclonal antibodies | Treatment escalation | Glatirameracetate | Interferon β | Multiple sclerosis | Randomized trials | Immunotherapy | Monoclonal antibodies | interferon beta | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | NEUTRALIZING ANTIBODIES | CLINICAL NEUROLOGY | 1ST DEMYELINATING EVENT | GLATIRAMER ACETATE COPAXONE(R) | INTERFERON-BETA THERAPY | DOUBLE-BLIND | INTRAVENOUS IMMUNOGLOBULIN TREATMENT | PLACEBO-CONTROLLED TRIAL | CLINICALLY ISOLATED SYNDROMES | MITOXANTRONE-INDUCED CARDIOTOXICITY | Azathioprine - therapeutic use | Multiple Sclerosis - diagnosis | Natalizumab | Humans | Antibodies, Monoclonal - adverse effects | Health Planning Guidelines | Glatiramer Acetate | Antibodies, Monoclonal - therapeutic use | Interferon-beta - therapeutic use | Antibodies, Monoclonal, Humanized | Societies - standards | Mitoxantrone - therapeutic use | Antibodies, Monoclonal - pharmacology | Europe | Immunologic Factors - administration & dosage | Azathioprine - pharmacology | Immunoglobulins, Intravenous - pharmacology | Multiple Sclerosis - therapy | Peptides - pharmacology | Plasmapheresis | Randomized Controlled Trials as Topic | Magnetic Resonance Imaging | Immunoglobulins, Intravenous - therapeutic use | Interferon-beta - pharmacology | Mitoxantrone - pharmacology | Peptides - therapeutic use | Immunologic Factors - therapeutic use | Care and treatment | Health aspects | Patient outcomes | Index Medicus
Journal Article
Journal Article